{"id":1086,"date":"2020-09-08T23:10:41","date_gmt":"2020-09-08T23:10:41","guid":{"rendered":"https:\/\/weber-interim.works\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/"},"modified":"2020-09-28T09:05:34","modified_gmt":"2020-09-28T09:05:34","slug":"entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern","status":"publish","type":"post","link":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/","title":{"rendered":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tGeneral Manager and Site Leader\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Company:<\/x><\/g>Warner Chilcott Deutschland GmbH (part of Allergan plc)<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Role:<\/x><\/g>General Manager of Warner Chilcott Deutschland GmbH and site leader of the Weiterstadt Site<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Industry: <\/x><\/g>Pharmaceutical<\/p>\n

Revenue:<\/x><\/g>Allergan: $16 Billion
WCD: 100 Million \u20ac<\/p>\n

Employees: <\/x><\/g>Allergan: 17,000
WCD: 250<\/p>\n

Situation: <\/x><\/g>Site closing due to volume decline<\/p>\n

Headquarter:<\/x><\/g>Allergan: Dublin, Ireland<\/p>\n

Website:<\/x><\/g>www.allergan.de<\/g>
(now part of AbbVie)<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Responsibility (Revenue\/Employees): <\/strong><\/p>\n

    \n
  • 250 Employees<\/li>\n
  • 100 Million \u20ac<\/li>\n<\/ul>\n

    Context:<\/strong><\/p>\n

      \n
    • Development and Execution of a site shut down and closing plan, including sale of all tangible assets and subsequent closure of the entity.<\/li>\n
    • Ensure production until end of 2018 and additional product supply to support product transfes to other sites (Yearly product revenue approx. $500 million)<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      Actions:<\/strong><\/p>

        • Shut down and closing plan developed by local management team, alignment with global leadership team achieved and plan approved and budgeted by the board.<\/li>
        • Shut down project set up, led by local management team<\/li>
        • Communication plan developed and executed with site organizsation, works council\/union, authorities and media<\/li>
        • Innovative social plan agreed between management and works council\/union<\/li>
        • Execution of shut down according to plan as well as implementation of measures to support transfer of employees to new companies\u00a0<\/li>
        • Continuous alignment of actions via stake holder management with global functions (e.g. Corporate communications, global HR, global Facility Management)<\/li>
        • Site property and site equipment sold successfully<\/li>
        • Subsequent upstream merger of entity completed<\/li><\/ul><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t\t
          \n\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t

          Result:<\/strong><\/p>\n

            \n
          • Shut down executed according to plan (in budget, in time, product supply ensured) while generating additonal savings of $7 million vs. budget<\/strong><\/li>\n
          • Very good cooperation with global management, site organisation and works council\/union during closing phase<\/strong><\/li>\n
          • 98 % of employees stayed in the company until the targeted separation date, less than 1% court cases<\/strong><\/li>\n
          • Runner up in the Allergan \u201ePlant of the Year\u201c contest in the closing year (Competition between all 15 global manufacturing sites)<\/strong><\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
            \n\t\t\t\t\t\t
            \n\t\t\t\t\t
            \n\t\t\t
            \n\t\t\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Special Challenges:<\/strong><\/p>\n

            Over a period of 18 months between the shut down annoucement and the final closing, the site had to ensure market supply and realize additional preproduction to allow product transfers. This required a high level of employment and engagement until the last day, although eveybody knew that their employment would come to an end. <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

            General Manager and Site Leader<\/p>\n","protected":false},"author":1,"featured_media":1453,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"disabled","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"disabled","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7,1],"tags":[],"class_list":["post-1086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","category-unkategorisiert"],"yoast_head":"\nDevelopment and Execution of a site closing plan<\/title>\n<meta name=\"description\" content=\"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Development and Execution of a site closing plan\" \/>\n<meta property=\"og:description\" content=\"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company\" \/>\n<meta property=\"og:url\" content=\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\" \/>\n<meta property=\"og:site_name\" content=\"THORSTEN WEBER\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-08T23:10:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-28T09:05:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Motho\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Motho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\"},\"author\":{\"name\":\"Motho\",\"@id\":\"https:\/\/weber-interim.works\/en\/#\/schema\/person\/e6465e08f5f2af39d0ec3d170e93cd3d\"},\"headline\":\"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company\",\"datePublished\":\"2020-09-08T23:10:41+00:00\",\"dateModified\":\"2020-09-28T09:05:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\"},\"wordCount\":359,\"publisher\":{\"@id\":\"https:\/\/weber-interim.works\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg\",\"articleSection\":{\"1\":\"Unkategorisiert\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\",\"url\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\",\"name\":\"Development and Execution of a site closing plan\",\"isPartOf\":{\"@id\":\"https:\/\/weber-interim.works\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg\",\"datePublished\":\"2020-09-08T23:10:41+00:00\",\"dateModified\":\"2020-09-28T09:05:34+00:00\",\"description\":\"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company\",\"breadcrumb\":{\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage\",\"url\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg\",\"contentUrl\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/weber-interim.works\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/weber-interim.works\/en\/#website\",\"url\":\"https:\/\/weber-interim.works\/en\/\",\"name\":\"THORSTEN WEBER\",\"description\":\"for pharma, consumer goods & friends\",\"publisher\":{\"@id\":\"https:\/\/weber-interim.works\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/weber-interim.works\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/weber-interim.works\/en\/#organization\",\"name\":\"THORSTEN WEBER\",\"url\":\"https:\/\/weber-interim.works\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/weber-interim.works\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-logo-800.png\",\"contentUrl\":\"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-logo-800.png\",\"width\":800,\"height\":162,\"caption\":\"THORSTEN WEBER\"},\"image\":{\"@id\":\"https:\/\/weber-interim.works\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/weber-interim.works\/en\/#\/schema\/person\/e6465e08f5f2af39d0ec3d170e93cd3d\",\"name\":\"Motho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/weber-interim.works\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d65deda8390e230920981ba6374841c0f0f25587cb67291e2bb0ee7da3363648?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d65deda8390e230920981ba6374841c0f0f25587cb67291e2bb0ee7da3363648?s=96&d=mm&r=g\",\"caption\":\"Motho\"},\"url\":\"https:\/\/weber-interim.works\/en\/author\/motho\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Development and Execution of a site closing plan","description":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/","og_locale":"en_US","og_type":"article","og_title":"Development and Execution of a site closing plan","og_description":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company","og_url":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/","og_site_name":"THORSTEN WEBER","article_published_time":"2020-09-08T23:10:41+00:00","article_modified_time":"2020-09-28T09:05:34+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-01.jpg","type":"image\/jpeg"}],"author":"Motho","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Motho","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#article","isPartOf":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/"},"author":{"name":"Motho","@id":"https:\/\/weber-interim.works\/en\/#\/schema\/person\/e6465e08f5f2af39d0ec3d170e93cd3d"},"headline":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company","datePublished":"2020-09-08T23:10:41+00:00","dateModified":"2020-09-28T09:05:34+00:00","mainEntityOfPage":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/"},"wordCount":359,"publisher":{"@id":"https:\/\/weber-interim.works\/en\/#organization"},"image":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage"},"thumbnailUrl":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg","articleSection":{"1":"Unkategorisiert"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/","url":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/","name":"Development and Execution of a site closing plan","isPartOf":{"@id":"https:\/\/weber-interim.works\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage"},"image":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage"},"thumbnailUrl":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg","datePublished":"2020-09-08T23:10:41+00:00","dateModified":"2020-09-28T09:05:34+00:00","description":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company","breadcrumb":{"@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#primaryimage","url":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg","contentUrl":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-projekt-001.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/weber-interim.works\/en\/entwicklung-und-umsetzung-eines-werksschliesungsplans-mit-anschliesender-verschmelzung-der-gesellschaft-fur-einen-pharmakonzern\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/weber-interim.works\/en\/"},{"@type":"ListItem","position":2,"name":"Development and Execution of a site closing plan including subsequent merger of entities for a pharmaceutical company"}]},{"@type":"WebSite","@id":"https:\/\/weber-interim.works\/en\/#website","url":"https:\/\/weber-interim.works\/en\/","name":"THORSTEN WEBER","description":"for pharma, consumer goods & friends","publisher":{"@id":"https:\/\/weber-interim.works\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/weber-interim.works\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/weber-interim.works\/en\/#organization","name":"THORSTEN WEBER","url":"https:\/\/weber-interim.works\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/weber-interim.works\/en\/#\/schema\/logo\/image\/","url":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-logo-800.png","contentUrl":"https:\/\/weber-interim.works\/wp-content\/uploads\/2020\/08\/weber-interim-works-interim-manager-logo-800.png","width":800,"height":162,"caption":"THORSTEN WEBER"},"image":{"@id":"https:\/\/weber-interim.works\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/weber-interim.works\/en\/#\/schema\/person\/e6465e08f5f2af39d0ec3d170e93cd3d","name":"Motho","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/weber-interim.works\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d65deda8390e230920981ba6374841c0f0f25587cb67291e2bb0ee7da3363648?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d65deda8390e230920981ba6374841c0f0f25587cb67291e2bb0ee7da3363648?s=96&d=mm&r=g","caption":"Motho"},"url":"https:\/\/weber-interim.works\/en\/author\/motho\/"}]}},"_links":{"self":[{"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/posts\/1086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/comments?post=1086"}],"version-history":[{"count":9,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/posts\/1086\/revisions"}],"predecessor-version":[{"id":1184,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/posts\/1086\/revisions\/1184"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/media\/1453"}],"wp:attachment":[{"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/media?parent=1086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/categories?post=1086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/weber-interim.works\/en\/wp-json\/wp\/v2\/tags?post=1086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}